Objective: Neonatal white matter injury (NWMI) is a lesion found in preterm infants that can lead to cerebral palsy. Although antagonists of bone morphogenetic protein (BMP) signaling, such as Noggin, promote oligodendrocyte precursor cell (OPC) production after hypoxic-ischemic (HI) injury, the downstream functional targets are poorly understood. The basic helix-loop-helix protein, oligodendrocyte transcription factor 1 (Olig1), promotes oligodendrocyte (OL) development and is essential during remyelination in adult mice. Here, we investigated whether Olig1 function is required downstream of BMP antagonism for response to injury in the neonatal brain. Methods: We used wild-type and Olig1-null mice subjected to neonatal stroke and postnatal neural progenitor cultures, and we analyzed Olig1 expression in human postmortem samples from neonates that suffered HI encephalopathy (HIE). Results: Olig1-null neonatal mice showed significant hypomyelination after moderate neonatal stroke. Surprisingly, damaged white matter tracts in Olig1-null mice lacked Olig2 1 OPCs, and instead proliferating neuronal precursors and GABAergic interneurons were present. We demonstrate that Noggin-induced OPC production requires Olig1 function. In postnatal neural progenitors, Noggin governs production of OLs versus interneurons through Olig1-mediated repression of Dlx1/2 transcription factors. Additionally, we observed that Olig1 and the BMP signaling effector, phosphorylated SMADs (Sma-and Mad-related proteins) 1, 5, and 8, were elevated in the subventricular zone of human infants with HIE compared to controls. Interpretation: These findings indicate that Olig1 has a critical function in regulation of postnatal neural progenitor cell production in response to Noggin.
H uman neonatal white matter injury (NWMI) is a complication observed in very low and extremely low birth-weight preterm infants. NWMI has been associated with development of cerebral palsy (CP), a lifelong condition with variable motor features including chronic spastic paraplegia and dysarthria. 1, 2 Neuroimaging and pathological studies have highlighted changes in the nature of lesions of NWMI over the past few decades. Whereas focal cystic necrotic lesions (aka, periventricular leukomalacia) were characteristic pathological hallmarks in the 1980s, it is now more common to find diffuse noncystic white matter injury (WMI). 3 The oligodendrocyte (OL) is the myelinating cell of the central nervous system (CNS) and has long been considered a cellular target in NWMI. Pathological studies provide evidence for arrest of oligodendrocyte precursor cell (OPC) maturation in NWMI, which is predicted to lead to a failure in myelination of white matter tracts. [4] [5] [6] We have shown that OPCs in such lesions express markers of Wnt signaling, a pathway that can cause OPC maturation arrest. [7] [8] [9] In this study, we investigated the function of the basic helix-loop-helix protein oligodendrocyte transcription factor 1 (Olig1) in hypoxic-ischemic (HI) neonatal diffuse gliotic WMI. Olig1 and Olig2 have critical roles in OPC specification, maturation, and myelination, and Olig1 is essential for establishment of OPCs from the ventral forebrain. 10, 11 In the embryonic forebrain, Olig1
regulates cell-fate choice between interneuron and OPC specification, 11 and mice lacking Olig1 function show exaggerated production of calretinin-and parvalbuminpositive interneurons at the expense of OPCs. Might these mechanisms also have relevance in progenitor cell responses to WMIs in the postnatal period? Bone morphogenetic proteins (BMPs) are secreted growth factors that are expressed in OPCs and OLs derived from the CNS. 12 The BMP pathway is activated upon ligand/ receptor formation, and phosphorylation of the intracellular SMAD (Sma-and Mad-related proteins) 1/5/8 protein complex is increased, with each SMAD forming a heteromeric receptor complex with SMAD4. 13 Mice lacking the BMP receptor, BMPRIa, in Olig1-expressing progenitors show increased numbers of oligodendroglia and interneurons in the brain at birth. 14 Previous work
shows that repair of WMI requires the presence of OPCs recruited either from the local parenchyma or the subventricular zone (SVZ), [15] [16] [17] [18] and that the BMP antagonist, Noggin, promotes OPC production in the setting of such injuries. 19, 20 Previous studies show that Olig1 function is required for OPC differentiation in adult WMI, 21 and that Olig1 is upregulated in the neonatal SVZ after HI injury. 22 Here, we asked whether Olig1 was required for repair after neonatal brain injury and, more specifically, whether Noggin-induced oligodendrogliogenesis requires Olig1. We subjected wild-type (WT) and Olig1-null animals to a standard model of neonatal stroke and observed a deficit of OPCs in the cerebral white matter. Surprisingly, we identified a large number of interneurons in the white matter. Olig1-null neuroepithelial cultures failed to produce OPCs in response to Noggin. Thus, Olig1 function is critical for the Noggin-induced production of OPCs in vitro and myelination post injury in vivo. Upregulation of Olig1 and activated BMP signaling proteins in human cases of neonatal HI encephalopathy (HIE) suggests clinical relevance of this mechanism. Mouse Neonatal HI Mouse pups were delivered normally with the day of birth considered as postnatal day P0. For a term stroke model, which encompasses WMI, cerebral HI was induced in P9 pups by right common carotid artery (CCA) cauterization followed by systemic hypoxia. Briefly, pups were lightly anesthetized with isoflurane (4% induction, 3% maintenance). Once fully anesthetized, a midline neck incision was made and the CCA was identified. The CCA was separated from the vagus nerve and then cauterized using a bipolar cauterizer at a power setting of 10. Animals were returned to the dam for 1.5 hours. Before exposure to hypoxia in humidified gas (10% O 2 /90% N 2 ), pups were prewarmed in jars for 20 minutes in a 37˚C water bath. Pups were then exposed to 65 minutes of hypoxia at 36˚C. After hypoxia, pups were allowed to recover in the jars for 20 minutes and were then returned to the dam for recovery periods of 2 to 4 weeks, at which point they were anesthetized and intracardially perfused with cold 4% paraformaldehyde (PFA) in 0.1 M of phosphate-buffered saline (PBS; pH 7.4). Brains were postfixed in the same solution and cryopreserved in 30% sucrose in 0.1M of PBS. For bromodeoxyuridine (BrdU) incorporation studies 1 week post-HI, WT and Olig1 2/2 pups were given daily intraperitoneal injections of BrdU (50mg/kg) from P14 to P16. All BrdU-injected mice were euthanized at P23. We scored "mild brain injury" as no detectable loss of volume on the ipsilateral side, "moderate brain injury" as preservation greater than two-thirds volume of ipsilateral versus contralateral hemisphere, and "severe brain injury" loss of greater than two-thirds volume of ipsilateral versus contralateral hemisphere. Table) . Cases 1 to 3 demonstrated clinical and pathological evidence of HIE and low-output state in multiple organs on postmortem examination. Specific findings in case 1 (2 months old, born at full term) included hypoplastic left heart and diffuse WMI in brain with focal neuron dropout in cerebral and cerebellar cortices. Case 2 (5 months old, born prematurely at 26 weeks gestation) had a clinical diagnosis of severe HIE and underwent therapeutic hypothermia, showed diffuse WMI on postmortem evaluation. Case 3 was 6 days old, born at 37 weeks and 4 days. Cases 4 to 7 were controls, with the following age and gestational age information: Case 4 was 7 months old, born at 31 weeks; case 5 was 2 days old, born at 37 weeks and 3 days; case 6 was born at 36 weeks and 4 days, and case 7 was 11 days old, born at 37 weeks and 6 days. The SVZ was the area examined in all cases.
Materials and Methods

Animals
Human Developmental Tissue
Immunohistochemistry in Human and Mouse Samples
Immunohistochemistry (IHC) was performed on 16-mm serial sections with blocking and antibody incubation carried out overnight at 48 C in PBS containing 0.3% Triton/10% normal goat serum, with the exception of glutamic acid decarboxylase 67 (GAD67), for which Triton was excluded. For human brains, cryosections were heated for antigen retrieval in sodium citrate buffer before blocking. Primary antibodies were used at the following dilutions: rabbit Olig2 ( ; rat platelet-derived growth factor receptor alpha (PDGFRa; 1:500; BD Biosciences); and rabbit pSMAD1/5/ 8 (1:1,000; Cell Signaling Technology). BrdU detection was carried out as previously described, 18 with IHC for the protein of interest carried out as described above before the application of the BrdU antibody. After primary antibody incubation and washes, sections were incubated with Alexa Fluor-conjugated, species-directed secondary antibodies (Invitrogen, Carlsbad, CA) and then rinsed before being mounted with 4',6-diamidino-2-phenylindole (DAPI) Fluoromount-G.
Cell Culture
Postnatal neurospheres and monolayer cultures were established from P7 microdissected SVZ from WT and Olig1-null animals and grown in Dulvecco's modified Eagle's medium/F12 (Invitrogen) supplemented with penicillin/streptavidin, N2, B27, epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF; 20ng/ml each). Cells were passaged once a week, which involved disassociating with trypsin (Life Technologies, Carlsbad, CA) followed by mechanical trituration. According to the experimental paradigm, cells were either cultured in the presence or absence of BMP4 (10ng/ml; R&D Systems, Minneapolis, MN) and Noggin (250ng/ml; R&D systems). Cells were 
Image Acquisition and Cell Counts
Confocal images were obtained using a Leica SPE upright microscope (Leica Microsystems, Jena, Germany) with the 40 3 objective, whereas fluorescent images were obtained using a Nikon 80i (Nikon, Tokyo, Japan) or Zeiss Axioskop2 (Carl Zeiss, Oberkochen, Germany) with the 20 3 objective. For IHC cell counts in mouse tissue, at least 3 animals per genotype were used and cells were counted on three or more nonadjacent sections. Likewise, for human tissue, there were at least 3 cases per condition and cells in the dorsolateral SVZ were counted on two nonadjacent sections. The borders of the dorsolateral SVZ were outlined using a drawing tool, and the areas were measured using Adobe Photoshop with the data being expressed as mean value/mm 2 6 standard error of the mean (SEM). For ICC cell counts, cells were quantified at two defined locations at the edge of each coverslip.
Quantitative Polymerase Chain Reaction
Total RNA was isolated from WT cells in culture using TRIzol reagent (Invitrogen) and then cleaned up with an RNeasy Mini Kit (Qiagen, Hilden, Germany). The complementary DNA (cDNA) was made using the High Capacity RNA to cDNA Master Mix (Applied Biosystems, Foster City, CA). All quantitative polymerase chain reaction (qPCR) was performed using SYBR Green master mix on a Roche Lightcycler 480 (Roche Diagnostics, Indianapolis, IN). Relative expression from RNA samples was determined using the 2 2DDCT method. Values were normalized to expression of the beta-actin housekeeping gene. Primers were designed using Primer3, and the sequences are as follows: Olig1: forward-GCTGCGCGAAGTTATCCTAC, reverse -ACCCAGCAGCAGGATGTAGT; distal-less homeobox (Dlx2): forward -CTGGCCTCAATTCCGACCT, reverse -GGCCTGAAGAGACCAAGGAC; Dlx1: forward -TTCCGTTCTGTTGTGTGTGG, reverse -GGTGGATTT-CAATCGGTCAC; Noggin: forward -GGTGTGTAAGCC ATCCAAGTCT, reverse -CCGAGTTCTAGCAGGAACACT TAC; Olig2: forward -GAAGCAGATGACTGAGCCCGAG, reverse -CCCGTAGATCTCGCTCACCAG.
Western Blot
Total cell lysate was collected from WT and Olig1-null cells in radioimmunoprecipitation buffer (Pierce, Rockford, IL), supplemented with proteinase and phosphatase inhibitor cocktails (Roche), resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis, and immunoblotted using standard techniques with the antibodies described above, in addition to mouse betaactin antibody (Sigma-Aldrich). Band intensity was measured using ImageJ software (NIH, Bethesda, MD).
Statistical Analyses
For all cell counts, statistical tests were performed using GraphPad Prism (GraphPad Software Inc., La Jolla, CA). One-way analysis of variance with Dunnett's multiple comparison test was used for comparison between groups, and Student's unpaired t test was used for two group comparisons. All cell counts and analyses were performed blind to experimental treatment. Data are expressed as mean 6 SEM.
Results
Olig1 Is Neuroprotective and Regulates OPC Versus Interneuron Production Following Neonatal Stroke
To investigate Olig1 function in the injury response, we subjected Olig1-null and WT animals to neonatal stroke 23 ( Fig 1A,B) . BrdU was administered 1 week post injury and animals were sacrificed 2 or 4 weeks postinjury (Fig 2B) . This procedure results in a variable extent of brain injury ( Figs 1A and 2A) . We selected only brains that had mild or moderate brain injury ipsilateral to the manipulated hemisphere (defined by the appearance of small cysts and/or ventriculomegaly with astrogliosis in the affected hemisphere) for analysis. Severely injured samples (defined as near-total ipsilateral hemispheric loss) were ruled out. At 2 and 4 weeks postinjury, Olig1 2/2 consistently showed increased brain injury compared to WT controls (Fig 1C,D) . After 2 and 4 weeks post injury, Olig1-null animals were more poorly myelinated compared to controls (Fig 1G,H,K,L) , despite the presence of intact axons (Fig 1I,J) . Indeed, we found surprising abnormalities in the ratios of neuron and glial precursor populations. First, populations of Olig2- (Fig 1G,H,M) and PDGFRa-labeled OPCs (Fig 1M) were greatly reduced in the corpus callosum of the Olig1-null animals 2 and 4 post injury. This was associated with significantly (p 5 0.01) decreased proliferation of Olig2-positive cells in Olig1-null animals compared to WT (Fig  2C,D,F) . We did not find the overall number of proliferating cells to be altered (BrdU 1 : WT, 155 6 42.7; Olig1-null, 181 6 14.8; p 5 0.59). Second, we asked whether the deficient population of OPC cells might relate to dysfunction in OPC specification, similar to what has FIGURE 4. been observed in the Olig1 2/2 embryonic forebrain.
Indeed, we observed a corresponding significant (p 5 0.01) increase in the number of proliferating DCXpositive cells in subcortical white matter of Olig1-null animals (Fig 2C,D,F) . In Olig1-null animals, DCXpositive cells colocalized with the neuron-specific marker, Tuj1, and the GABAergic interneuron protein GAD67, but not with Olig2 (data not shown; Fig 2E) . We never observed DCX/GAD67 colabeled cells in white matter of WT animals. These findings indicate that Olig1 function is required to regulate OL production in postnatal forebrain after HI injury. In the absence of Olig1, neural precursors adopt an interneuron fate, which then invade the cerebral white matter.
Noggin-Induced OPC Production Requires Olig1
Injury to white matter tracts can stimulate SVZ cells to increase production of neural progenitors for repair. 15, 17, 24, 25 In the setting of such injuries, the BMP antagonist, Noggin, is an inducer of the oligodendrogenic response of neural precursor cells. 19, 20 We assessed
Olig1 and Noggin expression in the SVZ of WT animals 7 days after HI injury and found elevated messenger RNA (mRNA) levels for Olig1 and Noggin in injured animals compared to sham controls (data not shown).
Noggin can promote production of OLs. 12, 19, 26 To determine a role for Olig1 downstream of Noggin, we generated both neurospheres and adherent cultures of neural stem cells (NSCs) from P7 dorsal SVZ of WT and Olig1-null animals in a biochemically defined medium or medium supplemented with BMP4 (10ng/ml), Noggin (250ng/ml), or BMP41Noggin (10 and 250ng/ml). In WT NSCs, adherent cultures expanded in EGF and FGF and supplemented with Noggin, both Olig1 mRNA and protein were induced after 6 hours (Fig 3A,B) . To investigate Noggin-induced programs of differentiation, we transferred WT and Olig1-null adherent cultures to growth-factor-free media for 7 days. As shown (Fig  3C,D) , Olig1-null cultures produced significantly fewer OPCs and immature OLs (Nkx2.2 1 and O4 1 ) and fewer mature OLs (GalC 1 ) at baseline compared to WT.
Whereas addition of Noggin to WT cultures significantly expanded the counts of OL lineage cells, Olig1-null cultures failed to respond to Noggin treatment. In keeping with this, qPCR and western blot analyses of Olig1-null cultures treated with Noggin showed decreased expression of OL markers compared to WT cultures (Fig 3E-G) . These data indicate that Olig1 is required for the Noggin-induced production of OLs from neural precursors.
Noggin Treatment Represses Dlx1/2 in an Olig1-Dependent Manner Given the observation that Olig1 represses embryonic interneuron production by inhibiting Dlx1/2 expression, 11 one possibility was that Noggin-induced OPC production from neuroprogenitors involved Olig1-mediated repression of Dlx1 and/or Dlx2. We therefore assessed Noggin-treated Olig1-null cultures for their ability to produce interneuron monolayer cultures. Olig1-null neurospheres, both in the presence and absence of Noggin, produced more DCX-positive immature neurons (which did not colabel with Olig2) and fewer Olig2-positive cells (Fig 4A,B) . There was a trend in Olig1-null monolayer cultures treated with Noggin to produce fewer GABAergic interneurons; however, this condition was not significant. We next tested whether BMP signaling regulates the interneuron versus OL fate choice through Dlx1 and/or Dlx2. Indeed, Olig1-null mutants show increased expansion of Dlx1 and Dlx2 expression in the embryonic brain. 11 As shown (Fig 4C) , qPCR analysis of WT adherent cultures treated with BMP4, Noggin, or BMP41Noggin showed that BMP4 induced upregulation of Dlx1 and Dlx2 transcript levels while reducing mRNA for Olig2. Taken together, these findings suggest that Olig1 function mediates Noggin-induced repression of Dlx1/2 in adherent neuroepithelial cultures (Fig 4D) .
Evidence for Olig1 Upregulation and BMP Pathway Activation in Human Neonatal SVZ Progenitors Following HI Injury
To assess the relevance of these findings to human brain injury, we first investigated the expression of Olig1 proteins in the dorsolateral SVZ of term human neonate HIE cases and controls ( Fig 5) . As shown (Fig 5B,C,H ), (Fig 5D,E) . In control and HIE cases, Olig1 colocalized with pSMAD1/5/8 in SVZ progenitors (Fig 5F,G 
Discussion
It is important to identify the underlying mechanisms and new therapeutic targets for NWMI. In this study, we interrogated the function of the OL transcription factor, Olig1, in HI neonatal diffuse gliotic WMI. Our results show that Olig1 is a potent regulator of GABAergic interneuron versus OL cell-fate acquisition in the injured white matter. They demonstrate that Olig1 is required for OL production and myelin generation in the context of NWMI, and that Olig1 functions downstream of Noggin signaling to promote postnatal production of OPCs.
Olig1 Regulation During Development and Post Injury Early Olig1 expression in the ventral telencephalon in vivo and in embryonic neural progenitors in vitro is regulated by Sonic hedgehog (Shh), 11, 27 suggesting that Shh initially induces Olig1 and patterns the embryonic septum and medial ganglionic eminence. Noggin also participates in early neural patterning events by antagonizing BMPs and working synergistically with Shh to promote ventral cell fates. 28 BMP treatment of embryonic mouse ventral neuroepithelial explants inhibits Shh induced oligodendrogliogenesis, but fails to fully inhibit this process once it has already been initiated at E6, indicating a role for BMP in early cell-fate specification. 29 At later stages and in the setting of neonatal brain injury where BMP expression is increased, 30 , but not Olig2. Although the white matter has a large number of these interneurons, it is not clear whether findings in Olig1-null mice are attributed to aberrant migration of progenitors into the white matter or expansion of rare resident progenitors that differentiate into interneurons. Future work will be needed to show the origin of the cells and whether they fully differentiate. Our in vitro data show increased production of GABAergic interneurons in Olig1-null progenitors at baseline, which is reminiscent of Olig1's role to regulate interneuron versus OPC fate in the embryonic telencephalon. In the embryo, Olig1 represses the domain of Dlx1/2 expression to preserve a progenitor cohort for later-wave OPC production. 11 The situation in the postnatal SVZ and in progenitors in culture is obviously spatiotemporally quite different. Nevertheless, Olig1 exerts a similar role in both contexts to repress Dlx1/2 and promote OPC production at the expense of interneurons. As an aside, this finding could be exploited for production of interneurons, for example, to inhibit seizure activity in animal models, 33 given that Olig1 2/2 neural progenitors overproduce interneurons.
Olig1 Functions Downstream of BMP Signaling
Inhibition by Noggin to Promote OPC Production After HI Injury Response to brain injury provides another instance of regulation of neurogenesis in the SVZ progenitors. For instance, subsequent to focal toxic damage to white matter with lysolethicin, SVZ progenitors are activated to produce OPCs versus neurons, 16 through activity of Noggin. 19, 26 These studies highlight the regenerative capacity of SVZ progenitors, particularly in adult WMI. Previous studies have shown that the SVZ expands after neonatal HI injury, 15, 22, 34, 35 and that Olig1 transcript levels are elevated post HI. 22 Indeed, in the human neonate with HIE, we found elevated numbers of Olig1-positive cells compared to controls. Moreover, consistent with a role for BMP signaling regulation, the majority of the Olig1-positive cells coexpressed pSMAD1/5/8. Further work is needed to determine whether BMP signaling in Olig1-positive progenitors would block or delay OPC maturation in the setting of HIE, but findings from this and other studies suggest the importance of the BMP antagonism by Noggin or similar agents to promote OPC production in stroke, 32 perinatal HI, 36 perinatal intraventricular hemorrhage, 37 intrauterine growth retardation, 38 and myelin-deficient animals. 39 Our model is one of term neonatal stroke, and further work is needed to show a role for Olig1 in other models of preterm NWMI. However, these studies suggest the benefit of Noggin and Olig1 activities in neonatal brain injury.
